EC

EcoR1 Capital Portfolio holdings

AUM $1.69B
This Quarter Return
+37.15%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$1.8B
AUM Growth
+$1.8B
Cap. Flow
+$175M
Cap. Flow %
9.73%
Top 10 Hldgs %
62.46%
Holding
77
New
29
Increased
3
Reduced
8
Closed
11

Top Buys

1
STTK icon
Shattuck Labs
STTK
$129M
2
SPRY icon
ARS Pharmaceuticals
SPRY
$117M
3
SLDB icon
Solid Biosciences
SLDB
$60.5M
4
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
$19.8M
5
ORIC icon
Oric Pharmaceuticals
ORIC
$15.2M

Top Sells

1
KURA icon
Kura Oncology
KURA
$92.6M
2
STRO icon
Sutro Biopharma
STRO
$65.6M
3
ASMB icon
Assembly Biosciences
ASMB
$41.9M
4
SURF
Surface Oncology, Inc. Common Stock
SURF
$30.4M
5
CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
$11.4M

Sector Composition

1 Healthcare 97.02%
2 Financials 0.52%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VINC
26
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$10M 0.54% 480,505 -150,000 -24% -$3.14M
ACRS icon
27
Aclaris Therapeutics
ACRS
$209M
$9.77M 0.53% 1,509,812 -21,500 -1% -$139K
ALPN
28
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$9.34M 0.5% 741,290 – –
TNGX icon
29
Tango Therapeutics
TNGX
$747M
$9.15M 0.49% 800,000 – –
ITOS icon
30
iTeos Therapeutics
ITOS
$8.79M 0.47% 260,000 – –
CMAX
31
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$7.51M 0.4% +481,600 New +$7.51M
CERE
32
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$6.63M 0.36% +400,000 New +$6.63M
CCCC icon
33
C4 Therapeutics
CCCC
$185M
$6.63M 0.36% +200,000 New +$6.63M
KYMR icon
34
Kymera Therapeutics
KYMR
$2.95B
$6.2M 0.33% 100,000 – –
LOGC
35
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$5.91M 0.32% +775,000 New +$5.91M
JYAC
36
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$5.15M 0.28% +500,000 New +$5.15M
OBIO icon
37
Orchestra BioMed
OBIO
$147M
$5.12M 0.28% 400,000 – –
PANA.U
38
DELISTED
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
$4.98M 0.27% 390,000 – –
CYCN icon
39
Cyclerion Therapeutics
CYCN
$7.91M
$4.92M 0.26% 1,606,276 -1,136,000 -41% -$3.48M
GLPG icon
40
Galapagos
GLPG
$2.07B
$4.62M 0.25% +46,666 New +$4.62M
DYN icon
41
Dyne Therapeutics
DYN
$1.92B
$4.52M 0.24% 215,000 – –
NGM
42
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$4.35M 0.23% +143,567 New +$4.35M
CDAK
43
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$3.72M 0.2% +115,195 New +$3.72M
VINCW
44
DELISTED
Vincerx Pharma, Inc. Warrant
VINCW
$3.14M 0.17% +150,000 New +$3.14M
PMVP icon
45
PMV Pharmaceuticals
PMVP
$74.2M
$3.08M 0.17% 50,000 – –
GOSS icon
46
Gossamer Bio
GOSS
$562M
$2.85M 0.15% +294,221 New +$2.85M
MTCR
47
DELISTED
Metacrine, Inc. Common Stock
MTCR
$2.62M 0.14% 333,332 – –
MLTX icon
48
MoonLake Immunotherapeutics
MLTX
$3.54B
$2.27M 0.12% +200,000 New +$2.27M
BLSA
49
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$2.23M 0.12% +200,000 New +$2.23M
SNCE
50
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$2.13M 0.11% +200,000 New +$2.13M
1
2
3 4